A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Metropolis Healthcare has launched a Centre for Genomics to expand its specialty diagnostics business. The company plans to ...
A genomic test for successfully predicting whether cancer will resist common types of chemotherapy has been developed. Cancer Research UK (CRUK) funded scientists at the University of Cambridge (UK), ...
A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...
Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic ...
Today, the Nature Health journal has published Monash University’s DNA Screen study results. The study piloted the idea of ...
To diagnose hereditary angioedema (HAE), doctors will run a series of blood tests as well as genetic testing if needed. Hereditary angioedema (HAE) is a genetic condition that causes episodes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback